(Q53614139)

16 May 2018

title

Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation. (English)

1 reference

16 May 2018

0 references

4

Brian D Hoit

1 reference

16 May 2018

author name string

Frank C Chen

1

1 reference

16 May 2018

Ozgur Ogut

2

1 reference

16 May 2018

Albert Y Rhee

3

1 reference

16 May 2018

Frank V Brozovich

5

1 reference

16 May 2018

publication date

3 July 2006

1 reference

16 May 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

16 May 2018

volume

41

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

488-495

1 reference

16 May 2018

Endothelium-dependent vasodilation is attenuated in patients with heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Improving clinical outcomes with drug treatment in heart failure: what have trials taught?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Oxidative stress in arterial hypertension: role of NAD(P)H oxidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Vascular reactivity in heart failure: role of myosin light chain phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Impaired nitric oxide-mediated renal vasodilation in rats with experimental heart failure: role of angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Myosin light chain phosphatase: subunit composition, interactions and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Unzipping the Role of Myosin Light Chain Phosphatase in Smooth Muscle Cell Relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Changes in skeletal muscle biochemistry and histology relative to fiber type in rats with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Simple techniques for the surgical occlusion of coronary vessels in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Acute and chronic captopril, but not prazosin or nifedipine, normalize alterations in adrenergic intracellular Ca2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Tumor necrosis factor-alpha-induced activation of RhoA in airway smooth muscle cells: role in the Ca2+ sensitization of myosin light chain20 phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Tumour necrosis factor-alpha activates a calcium sensitization pathway in guinea-pig bronchial smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Role of alpha1-adrenoreceptors in cocaine-induced NADPH oxidase expression and cardiac dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.05.018

10.1016/J.YJMCC.2006.05.018

7 January 2021

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

16815432

1 reference

16 May 2018